Clinical Trial Update: A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the neurological effects of adding maraviroc to HAART in HIV patients with HAND; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorders

Drugs mentioned

• HAART (Highly Active Antiretroviral Therapy)
• Maraviroc (maraviroc)

Snippet

Sponsor: Bruce Brew | Conditions: Human Immunodeficiency Virus (HIV), HIV Associated Neurocognitive Disorders (HAND) | Phase 4 | Status: COMPLETED | Results posted: 2016-05-20